Ingram Medical
Ingram Medical improves the management of diabetes by providing quality testing supplies, oral medications and shipping services
About Ingram Medical
Ingram Medical, established in 2010, operated as a technology-driven healthcare distribution company with a focus on chronic care management, particularly for individuals with diabetes. The firm's business model was centered on a direct-to-consumer approach, providing diabetes testing supplies and oral medications directly to patients' homes on a monthly basis. This service was designed to help diabetics ensure they were using the correct supplies for optimal savings and health management. The company was founded in Orem, Utah, and by 2013, its founders had been recognized as Ernst & Young Entrepreneurs of the Year in the Utah region.
The company's platform was designed as a chronic care product and sales system. A key feature was its online Diabetes Health Center, which provided health-related information curated by a professional staff of nurses, nutritionists, and physicians. To access the services, prospective patients would provide their information, after which a Diabetic Benefits Specialist would contact them to identify a suitable medical supplier for their needs. This process, described as highly automated, contributed to a significant expansion, with the company reportedly growing its customer base by over 400% in the two years leading up to September 2013.
A significant milestone in the company's history was a $30 million Series B funding round in September 2013, led by Mercato Partners. This investment included strategic participation from entities like Intermountain Healthcare and StepStone Group, and it was intended to fuel further growth and expansion into other chronic care areas. At the time, Jeff Smith served as the CEO of Ingram Medical. According to Tracxn, Ingram Medical is now considered a deadpooled company.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2013 | $30M | $120M | Kickstart Fund · Mercato Partners · Intermountain Healthcare · StepStone Group | — |
Growth signals
Latest recorded traffic for Ingram Medical is 0 monthly website visits. Ingram Medical's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Ingram Medical in the Orem ecosystem
The Ingram Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Mercato Partners
Kickstart Fund
Intermountain Healthcare
StepStone Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ingram Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ingram Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





